ES2397234T3 - Composiciones estabilizadas de trombina - Google Patents

Composiciones estabilizadas de trombina Download PDF

Info

Publication number
ES2397234T3
ES2397234T3 ES08780809T ES08780809T ES2397234T3 ES 2397234 T3 ES2397234 T3 ES 2397234T3 ES 08780809 T ES08780809 T ES 08780809T ES 08780809 T ES08780809 T ES 08780809T ES 2397234 T3 ES2397234 T3 ES 2397234T3
Authority
ES
Spain
Prior art keywords
thrombin
sucrose
concentration
composition
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08780809T
Other languages
English (en)
Spanish (es)
Inventor
Richard I. Senderoff
Shan Jiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ES2397234T3 publication Critical patent/ES2397234T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ES08780809T 2007-06-15 2008-06-13 Composiciones estabilizadas de trombina Active ES2397234T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94422407P 2007-06-15 2007-06-15
US944224P 2007-06-15
PCT/US2008/066850 WO2008157304A2 (en) 2007-06-15 2008-06-13 Stabilized thrombin compositions

Publications (1)

Publication Number Publication Date
ES2397234T3 true ES2397234T3 (es) 2013-03-05

Family

ID=40132545

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08780809T Active ES2397234T3 (es) 2007-06-15 2008-06-13 Composiciones estabilizadas de trombina

Country Status (8)

Country Link
US (1) US8071090B2 (cg-RX-API-DMAC7.html)
EP (1) EP2167041B1 (cg-RX-API-DMAC7.html)
JP (1) JP5253501B2 (cg-RX-API-DMAC7.html)
AU (1) AU2008266094B2 (cg-RX-API-DMAC7.html)
CA (2) CA2937487C (cg-RX-API-DMAC7.html)
ES (1) ES2397234T3 (cg-RX-API-DMAC7.html)
IL (1) IL202306A (cg-RX-API-DMAC7.html)
WO (1) WO2008157304A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101558310B (zh) * 2006-12-21 2013-05-08 积水医疗株式会社 含凝血酶的溶液中的α-凝血酶的稳定化方法
EP2822474B1 (en) 2012-03-06 2018-05-02 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
US9149529B2 (en) 2012-10-24 2015-10-06 Orthovita, Inc. Stable compositions containing thrombin and methods for preparation and use thereof
EP3010419B1 (en) 2013-06-21 2020-05-20 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
IL229134A0 (en) 2013-10-29 2014-03-31 Omrix Biopharmaceuticals Ltd Compounds and methods for stabilizing thrombin activity
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ／エス 押し出し増強因子を含んでいる乾燥組成物
IL234246A0 (en) 2014-08-21 2014-11-30 Omrix Biopharmaceuticals Ltd Stabilized thrombin
CN106999621B (zh) 2014-10-13 2020-07-03 弗罗桑医疗设备公司 用于止血和伤口愈合的干组合物
BR112017013565B1 (pt) 2014-12-24 2021-12-28 Ferrosan Medical Devices A/S Seringa para retenção e mistura de primeira e segunda substâncias
US20160264954A1 (en) * 2015-03-13 2016-09-15 Vitrum Biologies Inc. Method of stabilizing thrombin and composition thereof
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
AU2019266529B2 (en) 2018-05-09 2024-05-23 Ethicon Inc. Method for preparing a haemostatic composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879369A (en) * 1972-05-12 1975-04-22 Abbott Lab Anti-coagulant isolation from malayan pit viper using affinity chromatography
US4696812A (en) 1985-10-28 1987-09-29 Warner-Lambert Company Thrombin preparations
JPS6440433A (en) * 1987-08-05 1989-02-10 Green Cross Corp Aqueous liquid composition of thrombin
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof
US20060083733A1 (en) * 2002-01-18 2006-04-20 Fumihide Nishio High-concentration preparation of soluble thrombomodulin
US7928147B2 (en) * 2002-04-11 2011-04-19 Teva Animal Health, Inc. Antimicrobial wash and carrier solutions, and uses thereof
AU2005265251B2 (en) 2004-06-22 2009-09-10 Baxter International Inc. Thrombin compositions
US20060270015A1 (en) * 2005-05-26 2006-11-30 Dan Pawlak Thrombin purification
JP2006160760A (ja) * 2006-02-03 2006-06-22 Tobishi Pharmaceut Co Ltd 血管壁内膜肥厚抑制剤

Also Published As

Publication number Publication date
US8071090B2 (en) 2011-12-06
AU2008266094A1 (en) 2008-12-24
EP2167041A2 (en) 2010-03-31
CA2937487A1 (en) 2008-12-24
JP5253501B2 (ja) 2013-07-31
CA2687968A1 (en) 2008-12-24
CA2937487C (en) 2018-01-09
IL202306A (en) 2014-07-31
US20080311104A1 (en) 2008-12-18
CA2687968C (en) 2016-09-27
IL202306A0 (en) 2010-06-30
JP2010529997A (ja) 2010-09-02
AU2008266094A8 (en) 2010-01-21
AU2008266094B2 (en) 2014-01-30
WO2008157304A3 (en) 2009-03-12
EP2167041B1 (en) 2012-11-07
WO2008157304A2 (en) 2008-12-24

Similar Documents

Publication Publication Date Title
ES2397234T3 (es) Composiciones estabilizadas de trombina
ES2313383T3 (es) Composiciones de trombina.
JP4879104B2 (ja) 高度に濃縮された、凍結乾燥された、および液体の、因子ｉｘ処方
ES2344687T3 (es) Formulacion de fibrinogeno liquida, estable en almacenamiento.
TWI593421B (zh) 凍乾的重組ｖｗｆ調配物
US6204036B1 (en) Stable transglutaminase preparations and processes for their production
AU2015367185B2 (en) Pharmaceutical composition comprising plasminogen and uses thereof
HU215263B (hu) VIII faktor csökkentett oxigéntartalmú vizes oldata
TR201809670T4 (tr) Faktör VII polipeptitlerinin stabilize edilmiş kompozisyonları.
KR20110049897A (ko) 인자 ⅶ 폴리펩티드의 안정화된 고체 조성물
WO1997019687A9 (en) Methods of production and use of liquid formulations of plasma proteins
US11911448B2 (en) Stable liquid thrombin compositions
JPWO1995016460A1 (ja) 可溶性トロンボモジュリン含有組成物
ES2300268T3 (es) Formulaciones de las hormonas de crecimiento.
ES2407134T3 (es) Composiciones hemostáticas farmacéuticamente estables
ES2640343T3 (es) Composición de transglutaminasa anhidra
ES2988461T3 (es) Composición farmacéutica que comprende condroitinasa ABC liofilizada, envase y procedimiento de fabricación de los mismos
EP1927658B1 (en) Thrombin compositions
HK40049456A (en) Stable liquid thrombin compositions